dr. west discusses afatinib and cetuximab combination in nsclc
Published 13 years ago • 793 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
8:38
afatinib plus cetuximab in resistant non-small cell lung cancer
-
1:35
dr. janjigian discusses afatinib and cetuximab for patients with egfr-mutant lung cancer
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations
-
1:35
dr. west discusses upcoming important clinical trials results
-
0:58
the activity of afatinib in lung cancer
-
1:05
dr. west discusses crizotinib in alk-nsclc trial results
-
0:45
dr. corey langer discusses afatinib in egfr-positive nsclc
-
8:47
study of 693 nsclc patients treated with afatinib
-
1:35
dr. bunn discusses afatinib for patients with egfr mutation
-
4:09
frontline afatinib in egfr-mutant nsclc
-
7:03
asco 2008: cetuximab for nsclc
-
3:07
efficacy and safety of afatinib vs erlotinib and gefitinib in egfr nsclc
-
1:31
dr. vokes on cetuximab for head and neck cancer
-
1:30
dr. langer on afatinib for advanced non-small cell lung cancer
-
2:10
afatinib versus erlotinib in patients with advanced scc
-
0:40
copy of dr. west on fda approval of frontline osimertinib in egfr nsclc
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
0:51
dr. tianhong (tina) li reviews the lux-lung 3 trial afatinib data
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer